Accessibility Menu
 
Arrow-Thin-Down
S&P 500
7,230.12
+0.3%
+21.11
Arrow-Thin-Down
DJI
49,499.27
-0.3%
-152.87
Arrow-Thin-Down
NASDAQ
25,114.44
+0.9%
+222.13
Arrow-Thin-Down
Bitcoin
$78,705.00
+0.4%
+$322.15
Arrow-Thin-Down
AAPL
$280.19
+3.3%
+$8.84
Arrow-Thin-Down
AMZN
$268.36
+1.2%
+$3.30
Arrow-Thin-Down
GOOG
$382.96
+0.3%
+$1.02
Arrow-Thin-Down
META
$608.57
-0.5%
-$3.34
Arrow-Thin-Down
MSFT
$414.40
+1.6%
+$6.62
Arrow-Thin-Down
NVDA
$198.61
-0.5%
-$0.96
Arrow-Thin-Down
TSLA
$390.97
+2.4%
+$9.34
Most Active StocksDaily Stock GainersDaily Stock Losers
Collegium Pharmaceutical logo

Collegium Pharmaceutical

(NASDAQ) COLL

Current Price$34.30
Market Cap$1.11B
Since IPO (2015)+179%
5 Year+54%
1 Year+27%
1 Month+3%

Collegium Pharmaceutical Financials at a Glance

Market Cap

$1.11B

Revenue (TTM)

$780.57M

Net Income (TTM)

$62.87M

EPS (TTM)

$1.72

P/E Ratio

19.99

Dividend

$0.00

Beta (Volatility)

0.62 (Low)

Price

$34.30

Volume

11,200

Open

$33.68

Previous Close

$34.30

Daily Range

$33.39 - $34.37

52-Week Range

$26.72 - $50.79

COLL News

SellAlert-Purple.png

Collegium's General Counsel Trims His Stake as the Company Doubles Down on ADHD

Seena HassounaMar 30, 2026
SellAlert-Red.png

Collegium Pharmaceutical EVP Sells Nearly 50,000 Shares Worth $2 Million

Andy GouldMar 25, 2026
SellAlert-Purple.png

Collegium Pharmaceutical EVP Sells COLL 17,600 Shares Amid Strong Close of 2025

Adé HennisJan 14, 2026
Foolcom-Featured.png

Collegium (COLL) Q2 Revenue Jumps 29%

Motley Fool Markets TeamAug 7, 2025
A woman looking at a set of indexes and graphs

Why Collegium Pharmaceutical Rose Nearly 10% on Tuesday

Eric VolkmanFeb 9, 2021
GettyImages-693870464

Investing $5,000 in These 2 Biotechs Could Make You Rich

Alex CarchidiOct 25, 2020
prescription-drugs-on-cash

3 Top Healthcare Stocks You Can Buy Now for Less Than $40

Cory RenauerOct 4, 2020
GettyImages-1162543608

Here's the Best Healthcare Stock on Robinhood to Buy Now

Zhiyuan SunSep 22, 2020
Page 1

COLL: Motley Fool Moneyball Superscore

66

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Collegium Pharmaceutical

Industry

Pharmaceuticals

Sector

Health Care

Employees

423

CEO

Vikram Karnani, MBA

Website

www.collegiumpharma.com

Headquarters

Stoughton, MA 02072, US

COLL Financials

Key Financial Metrics (TTM)

Gross Margin

59%

Operating Margin

23%

Net Income Margin

8%

Return on Equity

24%

Return on Capital

15%

Return on Assets

4%

Earnings Yield

5.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.11B

Shares Outstanding

32.41M

Volume

11.20K

Avg. Volume

499.99K

Financials (TTM)

Gross Profit

$463.26M

Operating Income

$187.08M

EBITDA

$401.00M

Operating Cash Flow

$329.32M

Capital Expenditure

$1.74M

Free Cash Flow

$327.58M

Cash & ST Invst.

$406.53M

Total Debt

$940.56M

Collegium Pharmaceutical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$205.45M

+12.9%

Gross Profit

$128.38M

+30.6%

Gross Margin

62.49%

N/A

Market Cap

$1.11B

N/A

Market Cap/Employee

$3.12M

N/A

Employees

357

N/A

Net Income

$16.96M

+35.3%

EBITDA

$303.57M

+214.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$534.03M

+23.3%

Accounts Receivable

$211.33M

-7.5%

Inventory

$40.91M

+15.1%

Long Term Debt

$910.15M

+14.7%

Short Term Debt

$30.41M

-53.8%

Return on Assets

3.79%

N/A

Return on Invested Capital

14.76%

N/A

Free Cash Flow

$122.36M

+45.5%

Operating Cash Flow

$123.05M

+45.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CRONCronos Group Inc.
$2.64-1.12%
AMPHAmphastar Pharmaceuticals, Inc.
$21.88-0.36%
PCRXPacira BioSciences, Inc.
$24.44-4.12%
GDRXGoodRx Holdings, Inc.
$2.55+8.05%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.30+0.03%

Questions About COLL

What is the current price of Collegium Pharmaceutical?

Collegium Pharmaceutical is trading at $34.30 per share.

What is the 52-week range for Collegium Pharmaceutical?

Over the past 52 weeks, Collegium Pharmaceutical has traded between $26.72 and $50.79.

How much debt does Collegium Pharmaceutical have?

As of the most recent reporting period, Collegium Pharmaceutical reported total debt of $936.43M.

How much cash does Collegium Pharmaceutical have on hand?

Collegium Pharmaceutical reported $251.10M in cash and cash equivalents in its most recent financial results.

What is Collegium Pharmaceutical’s dividend yield?

Collegium Pharmaceutical does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services